Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.

Future oncology (London, England) - 1 May 2021

Zhou Quan, Mei Ye-Dong, Yang Huai-Jie, Tao Ya-Ling

Abstract excerpt

Aim: The mechanistic role of inhibitor of DNA binding or differentiation (ID) family in ovarian cancer (OC) has remained unclear. Materials & methods: We used the Oncomine, GEPIA, Kaplan-Meier Plotter, cBioPortal, SurvExpress, PROGgene V2, TIMER, and FunRich to evaluate the prognostic value of IDs in patients with OC. Results: the mRNA transcripts of all IDs were markedly downregulated in OC compared with normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Genetic
Share to Datasets as Topic
Share to Down-Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Progression-Free Survival

Source

Identifiers

PMID: 33728938
DOI: 10.2217/fon-2020-1006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.PMID 33728938Read ↗

The Inhibitor of DNA Binding Family Regulates the Prognosis of Ovarian CancerSemantic proximity Read ↗

Novel gene signatures for prognosis prediction in ovarian cancerSemantic proximity Read ↗

Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysisSemantic proximity Read ↗

Comprehensive analysis of inhibitor of differentiation/DNA-binding gene family in lung cancer using bioinformatics methods.Semantic proximity Read ↗

The role of OIP5 in the carcinogenesis and progression of ovarian cancerSemantic proximity Read ↗

Identification of prognostic genes after platinum-based chemotherapy in ovarian cancerSemantic proximity Read ↗

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancerSemantic proximity Read ↗

The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancerSemantic proximity Read ↗

The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesisSemantic proximity Read ↗

Microarray‐based identification of genes associated with prognosis and drug resistance in ovarian cancerSemantic proximity Read ↗

NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2Semantic proximity Read ↗

Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.